Erasca
ERAS
14.12
-0.18
-1.26%
Erasca
US · ERAS
#2103 by market cap
Listed 2021
14.12
-0.18
-1.26%
Live - 5344 symbols - heartbeat 379s ago
· 2026-10-08 08:28
Pre-market
14.15
+0.21%
After-hours
14.12
0.00%
- Market cap
- 4.94B
- P/E (TTM)i
- -14.86
- P/Bi
- 13.64
- EPSi
- -0.44
- Div yieldi
- 0.00%
- 52W posi
- 54%
Reader sentiment
Are you bullish or bearish on ERAS?
Anonymous reader poll. Unscientific, not investment advice.
Revenue annual, last 7 years
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 3.68M | 7.96M | 22.62M | 32.99M | 37.70M | 41.73M | 38.55M |
| Research & development | 9.62M | 29.55M | 73.92M | 112.46M | 103.82M | 115.36M | 92.85M |
| Operating profit | -13.29M | -37.51M | -96.54M | -145.45M | -141.53M | -157.09M | -131.41M |
| Pretax profit | -12.04M | -101.66M | -122.76M | -242.81M | -125.04M | -161.65M | -124.55M |
| Tax | -- | -- | -- | -- | -- | -- | -- |
| Net profit | -12.04M | -101.66M | -122.76M | -242.81M | -125.04M | -161.65M | -124.55M |
| Basic EPS | 0 | -4 | -2 | -2 | -1 | -1 | 0 |
| Diluted EPS | -0.18 | -4.44 | -1.85 | -1.99 | -0.83 | -0.69 | -0.44 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | -- |
| Gross profit | -- | -- | -- | -- | -- | -- |
| Selling & admin expenses | 9.66M | 9.46M | 10.07M | 9.36M | 10.65M | 11.72M |
| Research & development | 25.97M | 21.17M | 22.47M | 23.24M | 27.27M | 35.90M |
| Operating profit | -35.63M | -30.63M | -32.55M | -32.60M | -37.91M | -47.62M |
| Pretax profit | -30.97M | -33.88M | -30.61M | -29.09M | -183.44M | -44.08M |
| Tax | -- | -- | -- | -- | -- | -- |
| Net profit | -30.97M | -33.88M | -30.61M | -29.09M | -183.44M | -44.08M |
| Basic EPS | 0 | 0 | 0 | 0 | -1 | 0 |
| Diluted EPS | -0.11 | -0.12 | -0.11 | -0.10 | -0.60 | -0.14 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 51.12M | 119.99M | 420.02M | 444.50M | 320.68M | 308.79M | 286.24M |
| Cash & ST investments | 50.37M | 118.70M | 414.48M | 435.62M | 312.35M | 298.31M | 276.08M |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 55.51M | 124.83M | 501.42M | 514.91M | 395.30M | 502.53M | 396.15M |
| Total current liabilities | 2.75M | 13.68M | 26.22M | 48.69M | 26.16M | 31.40M | 28.51M |
| Short-term debt | 726.00K | 877.00K | 285.00K | 1.31M | 3.97M | 4.62M | 5.07M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 69,116,000.00 | 238,809,000.00 | 44,887,000.00 | 103,056,000.00 | 78,611,000.00 | 79,027,000.00 | 70,983,000.00 |
| Total equity | -13.60M | -113.98M | 456.53M | 411.85M | 316.69M | 423.50M | 325.17M |
| Retained earnings | -13.74M | -115.40M | -238.17M | -480.97M | -606.01M | -767.66M | -892.21M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 314.62M | 310.66M | 299.93M | 286.24M | 253.78M | 278.44M |
| Cash & ST investments | 304.59M | 300.66M | 288.40M | 276.08M | 243.79M | 268.74M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 471.24M | 445.39M | 420.40M | 396.15M | 461.23M | 435.05M |
| Total current liabilities | 25.47M | 28.15M | 28.71M | 28.51M | 26.66M | 33.57M |
| Short-term debt | 4.79M | 4.71M | 4.89M | 5.07M | 5.25M | 5.44M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 71,742,000.00 | 73,128,000.00 | 72,515,000.00 | 70,983,000.00 | 67,706,000.00 | 73,185,000.00 |
| Total equity | 399.50M | 372.26M | 347.89M | 325.17M | 393.53M | 361.87M |
| Retained earnings | -798.63M | -832.51M | -863.12M | -892.21M | -1.08B | -1.12B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -10.38M | -32.69M | -79.60M | -103.26M | -101.22M | -109.42M | -95.46M |
| Depreciation & amortization | 310.00K | 540.00K | 829.00K | 2.64M | 3.73M | 3.81M | 3.11M |
| Free cash flow | -10.98M | -71.38M | -98.49M | -119.82M | -122.99M | -131.98M | -105.08M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | 0 | 317.00M | 95.25M | 0 | 239.06M | 0 |
| Ending cash balance | 29.58M | 65.69M | 360.90M | 284.63M | 93.48M | 68.15M | 74.21M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -31.56M | -20.53M | -21.66M | -21.71M | -27.38M | -27.27M |
| Depreciation & amortization | 822.00K | 787.00K | 755.00K | 743.00K | 723.00K | 716.00K |
| Free cash flow | -31.64M | -26.06M | -25.66M | -21.72M | -177.42M | -27.28M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 0 | 0 | 258.75M | 0 |
| Ending cash balance | 70.89M | 66.55M | 70.64M | 74.21M | 47.66M | 42.95M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -71.68 | -55.92 | -34.33 | -43.68 | -33.27 |
| ROA %i | -21.69 | -120.90 | -39.21 | -47.78 | -27.48 | -36.01 | -27.72 |
| ROIC %i | -- | -- | -67.50 | -52.58 | -33.77 | -42.87 | -33.30 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -47.78 |
| EBIT margin %i | -- | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | 18.59 | 8.77 | 16.02 | 9.13 | 12.26 | 9.84 | 10.04 |
| Quick ratioi | 18.32 | 8.68 | 15.81 | 8.95 | 11.94 | 9.50 | 9.68 |
| Debt / assetsi | 6.65 | 2.39 | 3.75 | 10.70 | 14.13 | 10.33 | 11.90 |
| LT debt / equityi | -- | -- | 4.05 | 13.06 | 16.39 | 11.16 | 12.94 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -45.82 | -31.16 | -32.00 | -33.27 | -69.86 | -78.25 |
| ROA %i | -37.47 | -26.42 | -26.90 | -27.72 | -59.42 | -65.25 |
| ROIC %i | -44.99 | -32.05 | -32.48 | -33.30 | -65.93 | -73.12 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -- | -- |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 12.35 | 11.04 | 10.45 | 10.04 | 9.52 | 8.29 |
| Quick ratioi | 11.96 | 10.68 | 10.04 | 9.68 | 9.14 | 8.01 |
| Debt / assetsi | 10.78 | 11.10 | 11.49 | 11.90 | 9.96 | 10.28 |
| LT debt / equityi | 11.52 | 12.01 | 12.48 | 12.94 | 10.34 | 10.85 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Quote time 2026-10-08 08:28:48 · For reference only, not investment advice and not tailored to your situation.